2023
Indy Hematology Review
2023 Management of Long-Term Survivors of Hematologic Malignancies
FEATURING
Sandra Garofalo
- 64 views
- April 28, 2023
Indy Hematology Review
Understanding and Managing Immune Effector Cell Toxicities in Hematologic Malignancies
FEATURING
David Reeves
- 74 views
- April 28, 2023
- 1
Indy Hematology Review
Indy Hematology Review 2023: Expert Case Discussions
FEATURING
Michael Wiemann,
Saad Usmani,
Joseph Mikhael,
Matthew Lunning,
Steven Treon,
Tycel Phillips,
Jennifer Woyach
- 79 views
- April 20, 2023
Indy Hematology Review
Indy Hematology Review 2023: Emerging Therapies in Hematologic Malignancies and Disorders
FEATURING
Ruemu Birhiray
- 69 views
- April 20, 2023
Indy Hematology Review
Emerging and Current Treatment of Amyloidosis and Waldenstrom’s Macroglobulinemia
FEATURING
Morie Gertz
- 203 views
- April 20, 2023
- 1
Indy Hematology Review
Recognizing Toxicities of Oral Oncolytics in the Management of Hematologic Malignancies in 2023
FEATURING
Kristi Orbaugh
- 32 views
- April 20, 2023
Indy Hematology Review
Sickle Cell Disease and Clotting Disorders of the Blood in 2023
FEATURING
Craig Kessler
- 101 views
- April 19, 2023
Indy Hematology Review
Managing Newly Diagnosed MM in 2023
FEATURING
Saad Usmani
- 248 views
- April 19, 2023
Indy Hematology Review
Targets and Treatments of MPNs in 2023
FEATURING
Ruben Mesa
- 330 views
- April 19, 2023
- 1
Indy Hematology Review
Current and Emerging Therapies for AML and MDS
FEATURING
Richard Larson
- 78 views
- April 19, 2023
Indy Hematology Review
Therapeutic Options in CLL in 2023: Choosing the Initial Therapy Wisely
FEATURING
Jennifer Woyach
- 1,167 views
- April 19, 2023
- 10
Indy Hematology Review
Jumping on a Moving Bullet Train: Emerging Treatments for Hodgkin Lymphoma
FEATURING
Matthew Lunning
- 73 views
- April 19, 2023
- 1
Indy Hematology Review
Advancing Therapeutic Outcomes in Aggressive B and T Cell Lymphomas
FEATURING
Tycel Phillips
- 133 views
- April 19, 2023
- 1
Indy Hematology Review
Beyond Hyperviscosity: 80 Years and Counting - Treatment of Waldenstrom’s Macroglobulinemia
FEATURING
Steven Treon
- 28 views
- April 19, 2023
Indy Hematology Review
DEBATE: Why Not to Transplant When MRD Has Been Achieved After Initial Therapy for MM
FEATURING
Joseph Mikhael
- 541 views
- April 19, 2023
- 3
Indy Hematology Review
DEBATE: Transplanting the MRD- Myeloma Patients for a Deeper Remission After Initial Therapy
FEATURING
Saad Usmani
- 323 views
- April 19, 2023
- 1
Indy Hematology Review
Indy Hematology Review 2023: Take Home Messages for MDS & AML
FEATURING
Rami Komrokji
- 97 views
- April 19, 2023
- 1
Indy Hematology Review
Indy Hematology Review 2023: Recent Important Results for Adult ALL
FEATURING
Charles A. Schiffer
- 68 views
- April 19, 2023
- 1
Indy Hematology Review
Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis Updates
FEATURING
Morie Gertz
- 712 views
- April 19, 2023
- 3
Indy Hematology Review
Controversies and Recommendations for the Treatment of ALL and Lymphoblastic Lymphoma in 2023
FEATURING
Wendy Stock
- 630 views
- April 19, 2023
- 1
Indy Hematology Review
Managing Indolent and Mantle Cell Lymphomas With Targeted and Cellular Therapies in 2023
FEATURING
Gilles Salles
- 151 views
- April 18, 2023
- 1
Indy Hematology Review
Emerging Therapies for R/R CLL
FEATURING
William Wierda
- 95 views
- April 18, 2023
Indy Hematology Review
Myelofibrosis: Chronic and Blast Phase - 2023 Algorithms for Risk Stratification and Treatment
FEATURING
Ayalew Tefferi
- 773 views
- April 18, 2023
- 3
Indy Hematology Review
Recent Updates on the Treatment of Polycythemia Vera
FEATURING
Angela Fleischman
- 370 views
- April 18, 2023
Indy Hematology Review
Updates on the Treatment of Myelofibrosis and FGFR-Mutated Myeloid Neoplasms
FEATURING
Angela Fleischman
- 223 views
- April 18, 2023
Indy Hematology Review
Emerging and Current Treatment of MM: What Should We Know and What Should We Do
FEATURING
Kenneth Anderson
- 649 views
- April 18, 2023
- 4
Indy Hematology Review
Hematopoietic Stem Cell Transplantation: State of the Art in 2023
FEATURING
Richard Childs
- 84 views
- April 18, 2023
Indy Hematology Review
Managing the Benign Hematology Consult: Treatment Recommendations for Coagulopathy, Cytosis, and Cytopenia
FEATURING
Craig Kessler
- 1,118 views
- April 18, 2023
- 7
Indy Hematology Review
Improving Outcomes With Current Therapies in AML and Acute Promyelocytic Leukemia: What We Recommend in 2023
FEATURING
Martin Tallman
- 64 views
- April 18, 2023
Indy Hematology Review
The Oracle of Apollo in Indianapolis: Prognosis and Treatment in MDS
FEATURING
Richard Stone
- 295 views
- April 18, 2023
Indy Hematology Review
Resistant or Recurrent CML and Prospective Discontinuation
FEATURING
Richard Larson
- 57 views
- April 18, 2023